Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.
Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific & Innovative Research, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.
Bioorg Chem. 2019 Sep;90:103062. doi: 10.1016/j.bioorg.2019.103062. Epub 2019 Jun 12.
Alkaloids have always been a great source of cholinesterase inhibitors. Numerous studies have shown that inhibiting acetylcholinesterase as well as butyrylcholinetserase is advantageous, and have better chances of success in preclinical/ clinical settings. With the objective to discover dual cholinesterase inhibitors, herein we report synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine (1) and its bromo-derivative 2. Our study has shown that cryptolepine (1) and its 2-bromo-derivative 2 are dual inhibitors of acetylcholinesterase and butyrylcholinesterase, the enzymes which are involved in blocking the process of neurotransmission. Cryptolepine inhibits Electrophorus electricus acetylcholinesterase, recombinant human acetylcholinesterase and equine serum butyrylcholinesterase with IC values of 267, 485 and 699 nM, respectively. The 2-bromo-derivative of cryptolepine also showed inhibition of these enzymes, with IC values of 415, 868 and 770 nM, respectively. The kinetic studies revealed that cryptolepine inhibits human acetylcholinesterase in a non-competitive manner, with ki value of 0.88 µM. Additionally, these alkaloids were also tested against two other important pathological events of Alzheimer's disease viz. stopping the formation of toxic amyloid-β oligomers (via inhibition of BACE-1), and increasing the amyloid-β clearance (via P-gp induction). Cryptolepine displayed potent P-gp induction activity at 100 nM, in P-gp overexpressing adenocarcinoma LS-180 cells and excellent toxicity window in LS-180 as well as in human neuroblastoma SH-SY5Y cell line. The molecular modeling studies with AChE and BChE have shown that both alkaloids were tightly packed inside the active site gorge (site 1) via multiple π-π and cation-π interactions. Both inhibitors have shown interaction with the allosteric "peripheral anionic site" via hydrophobic interactions. The ADME properties including the BBB permeability were computed for these alkaloids, and were found within the acceptable range.
生物碱一直是胆碱酯酶抑制剂的重要来源。大量研究表明,抑制乙酰胆碱酯酶和丁酰胆碱酯酶具有优势,并且在临床前/临床环境中更有可能取得成功。为了发现双重胆碱酯酶抑制剂,我们在此报告吲哚喹啉生物碱血根碱(1)及其溴代衍生物 2 的合成和生物学评价。我们的研究表明,血根碱(1)及其 2-溴代衍生物 2 是乙酰胆碱酯酶和丁酰胆碱酯酶的双重抑制剂,这两种酶参与阻断神经递质传递过程。血根碱抑制 Electrophorus electricus 乙酰胆碱酯酶、重组人乙酰胆碱酯酶和马血清丁酰胆碱酯酶的 IC50 值分别为 267、485 和 699 nM。血根碱的 2-溴代衍生物也表现出对这些酶的抑制作用,IC50 值分别为 415、868 和 770 nM。动力学研究表明,血根碱以非竞争性方式抑制人乙酰胆碱酯酶,ki 值为 0.88 µM。此外,这些生物碱还针对阿尔茨海默病的另外两个重要病理事件进行了测试,即阻止有毒淀粉样β寡聚体的形成(通过抑制 BACE-1),以及增加淀粉样β的清除(通过 P-糖蛋白诱导)。血根碱在 100 nM 时表现出强烈的 P-糖蛋白诱导活性,在 P-糖蛋白过表达的腺癌 LS-180 细胞中,以及在 LS-180 和人神经母细胞瘤 SH-SY5Y 细胞系中具有良好的毒性窗口。与 AChE 和 BChE 的分子建模研究表明,两种生物碱都通过多个 π-π 和阳离子-π 相互作用紧密地填充在活性位点峡谷(部位 1)内。两种抑制剂都通过疏水相互作用与变构的“外周阴离子结合位点”相互作用。对这些生物碱进行了 ADME 性质包括 BBB 渗透性的计算,结果发现它们都在可接受的范围内。